Clinical Trials Logo

Filter by:
NCT ID: NCT05590117 Enrolling by invitation - Colo-rectal Cancer Clinical Trials

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

Start date: October 11, 2022
Phase: Early Phase 1
Study type: Interventional

This study aims to: - Evaluate the possible protective effect of pentoxifylline against oxaliplatin induced peripheral neuropathy and chemotherapy induced mucositis in patients with stage II and stage III colorectal cancer. This study will be a randomized placebo controlled parallel study.48 patients with colorectal cancer will be randomized to 2 groups: Group I (control group; n=24) which will receive 12 cycles of FOLFOX-6 regimen plus placebo tablets twice daily. Group II (Pentoxiphylline group; n=24) which will receive FOLFOX-6 regimen in addition to pentoxifylline 400 mg twice daily. Blood sample collection and biochemical assessment: - Malondialdehyde (MDA) as oxidative stress marker (colorimetry). - Tumor necrosis factor alfa (TNF-α) as pro inflammatory marker (ELISA). - Neurotensin (NT) as a potential marker for neuropathic pain (ELISA). - Citrulline as a biomarker for mucositis (ELISA). Clinical assessment of oxaliplatin induced neuropathy will be done through: The assessment of the severity of neuropathic pain through "Brief Pain Inventory-Short Form" at baseline and by the end of every two chemotherapy cycles. The implication of National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE, Version 5, 2017) for grading of neuropathy every 2 cycles. The use of Neurotoxicity- 12 item questionnaire score (Ntx-12) from the validated Functional Assessment of Cancer Therapy/Gynecologic Oncology Group at baseline and by the end of every two chemotherapy cycles). Mucositis will be assessed at baseline and by the end of every two chemotherapy cycles through the use of common terminology criteria for adverse events "CTCAE, version 5.00, 2017

NCT ID: NCT05586009 Enrolling by invitation - Clinical trials for Cisplatin Adverse Reaction

Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients

Start date: October 2022
Phase: Phase 2
Study type: Interventional

The goal of this [ type of study: intervential study is to compare between different doses of magnesium to prevent cisplatin induced nephrotoxicity.] In 75 participant population with head and neck cancer recieved cisplatin it aims to answer are: • • optimal doses of magnesium as 3 groups each group take 1gm of magnesium then second group take 2gm of magnesium and finally third group take 3gm of magnesium Researchers will compare [ 3 groups ] to see if [ magnesium has effects in prevention cisplatin nephrotoxicity].

NCT ID: NCT05577260 Enrolling by invitation - Clinical trials for Abdominal Aortic Surgery

The Effect of Intraperitoneal Injection of Magnesium Sulphate Versus Dexmedetomidine as an Adjuvant to Bupivacaine on Postoperative Analgesia in Patients Undergoing Abdominal Aortic Surgery

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

optimal management of postoperative pain is essentiel for better outcome in abdominal aortic surgery.the study aim to compare between analgesic effect of magnesium sulphate versus dexmedetomidine as an adjuvant to bupivacaine when injected intraperitoneal in abdominal aortic surgery.METHODS:50 patients undergoing abdominal aortic surgery are randemelly divided into 2 groups.(group D:patients received 20ml isobaric bupivacaine+1mic/kg dexemedetomidine completed to 5ml normal saline) Group M:patients received 20ml isobaric bupivacaine+5mg magnesuim sulphate .postoperative VAS,MAP will be recorded initially then every 2hours.

NCT ID: NCT05550285 Enrolling by invitation - Clinical trials for Orbital Floor (Blow-Out) Open Fracture

3D Printed Titanium Mesh vs Guided Autogenous Graft

Start date: September 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

In this study, the hypothesis states that there is no significant difference between specified populations. In our case, the 3D printed patient-specific titanium mesh is thought to have the same effect and results in comparison with the computer-guided calvarial bone graft technique according to the related studies.

NCT ID: NCT05550116 Enrolling by invitation - White Spot Lesion Clinical Trials

Clinical Evaluation of White Spot Lesions Treated by S-PRG and ICON

Start date: August 11, 2021
Phase: N/A
Study type: Interventional

Randomized with (1:1) prospective, double-blind, controlled trial. Subjects will be randomized to receive S-PRG and the control group receives ICON.

NCT ID: NCT05543109 Enrolling by invitation - Pain, Postoperative Clinical Trials

Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block

Start date: September 29, 2022
Phase: N/A
Study type: Interventional

The aim of this study was to compare the intraoperative and the postoperative analgesic effect of psoas compartment block (PCB) and supra-inguinal fascia iliaca compartment block (SFIB) in pediatric patients undergoing developmental dysplasia of the hip

NCT ID: NCT05539924 Enrolling by invitation - Opioid Use Clinical Trials

Pregabalin Versus Gabapentin Opioid Sparing Effect in Discectomy

Start date: September 15, 2022
Phase: Phase 3
Study type: Interventional

Pregabalin and gabapentin are both GABA analogue and their mechanism of action is not fully understood. Both drugs when given as a pre-emptive analgesia for spinal surgery were found to reduce intra-and postoperative opioid requirements. Preoperative intramuscular injection of morphine could reduce the patients' pain during the percutaneous transformational endoscopic discectomy "PTED" surgery and improve the patients' satisfaction without affecting the surgical outcome. The efficacy of adding pregabalin or gabapentin to preoperative intramuscular morphine is not yet investigated. The current study aims to compare the analgesic effect of both drugs when given preoperatively with intramuscular morphine.

NCT ID: NCT05537506 Enrolling by invitation - Clinical trials for Moderate and Severe Crowding in Lower Dental Arch

Evaluation of Effects of Bracket's Slot System on the Quantity and Quality of Teeth Movements During Orthodontic Leveling and Alignment Stage

Start date: January 25, 2023
Phase: N/A
Study type: Interventional

Evaluation of effect of bracket slot system on the quality and quantity of tooth movement during leveling and alignment stage

NCT ID: NCT05529381 Enrolling by invitation - Anxiety Depression Clinical Trials

Anxiety and Depressive Symptoms in Placenta Previa / Accreta

Start date: November 26, 2022
Phase:
Study type: Observational

placenta previa is an obstetric complication which is associated with depression and anxiety. As little is known about the emotional reaction to the diagnosis of placenta previa/accrete, a study is badly needed to estimate the magnitude of this problem and its effects on the mother

NCT ID: NCT05475548 Enrolling by invitation - Clinical trials for Effect of PowerScope Appliance in Treatment of Patients With Class 3 Malocclusion

Effect of Skeletally Anchored Reversed PowerScope Appliance in Orthodontic Treatment of Patients With Class III Malocclusion

Start date: December 2022
Phase: N/A
Study type: Interventional

the PowerScope appliance is found to be efficient for the treatment of class II malocclusion. Accordingly, it appears valuable to investigate the efficiency of skeletally anchored powerScope in the treatment of class III malocclusion